Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures
NCT ID: NCT02074969
Last Updated: 2014-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2007-10-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures
NCT00736684
Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation
NCT01473082
Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™)
NCT02305121
FEA, Biomechanical and Clinical Study of R.O. Peritrochanteric Fractures With PFLP vs Cephalomedullary Nail.
NCT05286905
Re-Evaluation of GAmma3 Intramedullary Nails in Hip Fracture (REGAIN)
NCT00555945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All surgeries are performed by trauma surgeons at a Level 1 University Hospital. One hundred patients are randomized to the gamma nail and 100 are randomized to the proximal femoral nail for treatment fixation. A 1:1 randomization is performed using sealed envelopes (200 in total), which are opened by the surgeon immediately before the operation.
Patients missing an informed consent form, incomplete chart, or showing a pathologic fracture are getting excluded from final comparisons.
Patients anthropometric data as well as pre-injury mobility assessments, and ASA will be documented. Furthermore the time from admission to going to surgery, surgery length, length of stay and mobility assessment at dischargement are recorded.
After surgery the stay in the hospital is documented precisely and patients are scheduled for next appointments 2 weeks, 6 weeks, 3 months, 6 months and 1 year after surgery.
Postoperative X-rays are measured precisely to determine the Tip-Apex Distance (TAD), the Parkers-Ratio, the Singh-Score and the Neck-Shaft-Angle of the injured and contralateral side. Rates of complications as cut-out and reoperation-rates are evaluated. All intra-operative complications are noted and included in the chart.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gamma Nail 3
Gamma Nail 3 Stryker.
Gamma Nail 3
Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by Gamma Nail 3.
PFNA
PFNA Antirotation Synthes
PFNA
Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by PFNA.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gamma Nail 3
Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by Gamma Nail 3.
PFNA
Patients who have sustained an unstable pertrochanteric hip fracture are getting treated by PFNA.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 18 - 100 years
* Signed written informed consent and agreement to attend the planned FUs
* Able to understand and read country national language at an elementary level
Exclusion Criteria
* pathological fracture
* incomplete patient record
* death within one month of intervention (surgery)
* prior surgery to the hip
* polytrauma
* any additional fracture
* any implant at the same hip
* infection
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Harry Widhalm
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harald K. Widhalm, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Trauma, Medical University of Vienna, Austria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Trauma, Medical University of Vienna
Vienna, Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barton TM, Gleeson R, Topliss C, Greenwood R, Harries WJ, Chesser TJ. A comparison of the long gamma nail with the sliding hip screw for the treatment of AO/OTA 31-A2 fractures of the proximal part of the femur: a prospective randomized trial. J Bone Joint Surg Am. 2010 Apr;92(4):792-8. doi: 10.2106/JBJS.I.00508.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007406
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.